Suchergebnisse - "Merz, Valeria"

PubPharm (9)

1

Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma

enthalten in: Cancer research | 2024

von Pietrobono, S. | Sabbadini, F. | Bertolini, M. | +12

2

The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma

enthalten in: Cancer medicine | 2023

von Procaccio, L. | Merz, V. | Fasano, M. | +21

3

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

enthalten in: Nature medicine | 2023

von van de Haar, J. | Ma, X. | Ooft, S. | +47

CommentIn: Nat Rev Gastroenterol Hepatol. 2023 May;20(5):269. - PMID 37012321

4

Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion

enthalten in: JCO precision oncology | 2022

von Gaule, M. | Pesoni, C. | Quinzii, A. | +11

5

Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer

enthalten in: Journal for immunotherapy of cancer | 2021

von Melisi, D. | Oh, D. | Hollebecque, A. | +16

6

Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Merz, V. | Zecchetto, C. | Santoro, R. | +11

7

Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer

enthalten in: Molecular cancer therapeutics | 2020

von Santoro, R. | Zanotto, M. | Simionato, F. | +8

8

Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

enthalten in: JAMA surgery | 2019

von Maggino, L. | Malleo, G. | Marchegiani, G. | +21

CommentIn: JAMA Surg. 2019 Oct 1;154(10):942. - PMID 31339517

9

A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma

enthalten in: Oncoimmunology | 2017

von Piro, G. | Simionato, F. | Carbone, C. | +12

1
[1]